Skip to content

Three Quick Facts: J Sainsbury, Smith & Nephew and Topps Tiles


Three things you need to know in the financial markets this morning from investment writer, Tony Cross.

J Sainsbury

J Sainsbury [LON:SBRY] has published its Q1 trading statement this morning for the 16 week period to June 27th. Grocery sales are up 10.5%, clothing sales are down 26.7% and online sales more than doubled during the period. The company notes an outperformance in growth of market share during the period, although expansion of its online delivery service was dwarfed by that of rival Tesco. Despite the good start to the year, the company remains cautious over its outlook for the longer term.

Smith & Nephew

There may be a presumption that the COVID-19 pandemic has been good for the health sector, but med-tech Smith & Nephew [LON:SN] has published Q2 numbers today which debunk this myth. Lower levels of elective surgeries during the pandemic have limited sales and revenues for the quarter are around 29% lower. The company is keen to stress this is in line with expectations and the recovery is taking shape with June revenues just 12% lower. Assuming the virus remains in check, can a bounce be seen as hospitals and surgeons play catch up with a backlog of operations?

Topps Tiles

A Q3 update from Topps Tiles [LON:TPT] this morning, another company which has been hit by the shut down of UK retail in recent weeks. Sales for the quarter are 53% lower, although the June figure – down just 20% – is arguably a positive sign that the recovery is on track. There’s little in terms of outlook, although the Chief Executive notes that the business has proved resilient. With more that £50m worth of cash headroom, the company is in a sound position in terms of liquidity and should be well positioned to embrace the recovery.

One extra note – on Monday, we reported that Indivior’s CEO had stepped down rather abruptly. This morning the company notes that he has entered into an agreement with the Department of Justice in the US, pleading guilty to one misdemeanour count under the Responsible Corporate Officer Doctrine. The plea is in a personal capacity and not on behalf of the group, but with the company still working to resolve outstanding regulatory investigations, this remains one to watch in the future.

Sign up for three quick facts and more with our Free Daily Digest newsletter, every weekday morning.

Looking for great investing ideas? Sign up to our free newsletter.

This article does not constitute investment advice. Make sure you do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Site Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
CME Group
Back To Top